WASHINGTON (June 4, 2020) – The American Chemistry Council (ACC) issued the following statement in response to the U.S. Environmental Protection Agency (EPA) proposed rule, “Increasing Consistency and Transparency in Considering Benefits and Costs in the Clean Air Act Rulemaking Process.”
“We welcome EPA’s initiative to improve the use of cost-benefit analysis in rulemaking. EPA’s effort will de-mystify and standardize the process so that policymakers and the public understand the impacts of regulatory proposals and are empowered to make good decisions about where to invest resources. It will also support capital investment and R&D that drive economic growth. We look forward to an in-depth review of the proposal in the weeks ahead.
“ACC commends action to address the historical challenges with the consideration of regulatory costs and benefits. As a final rule is being crafted, we urge EPA to carefully consider a range of options, from a cost-benefit ‘test’ to specific process reforms. We look forward to providing
input to EPA, OMB and Congress.
“Ensuring a clear, consistent and accurate examination of costs and benefits in the regulatory process is a common-sense idea that has earned bipartisan support by presidents, policymakers and others over four decades. With thoughtful reforms, cost-benefit analysis can fulfill its
important role in regulatory review.”